Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix – A Systematic Literature Review and New Case Report with Possible New Therapeutic Approaches

Malignant schwannomas of the visceral organs are extremely rare. To date, 19 cases of cervical schwannoma have been reported in the literature worldwide. A single case prompted a review of the literature. The differential diagnosis between melanoma and schwannoma is made using the marker HMB-45, which is positive for melanoma and negative for schwannoma. This differentiation allowed us to identify two of the 20 cases that were probably not schwannomas. The prognosis of malignant cervical schwannoma is poor. Approximately half of the cases develop local recurrence or distant metastases within a short time, despite resection in healthy tissue. In one case, gene sequencing revealed a potential treatment approach with the mTOR inhibitor everolimus and trastuzumab. Unfortunately, the potential efficacy of these treatment options could not be tested because the patient was being treated at another hospital at the time of relapse, and they did not use a drug that matched the NGS profile.

Authors

Institutions

Publication Details

Journal
Geburtshilfe und Frauenheilkunde
Published
2024-12-10
DOI
https://doi.org/10.1055/a-2283-3714
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix – A Systematic Literature Review and New Case Report with Possible New Therapeutic Approaches

Zihao Hu, Zhi Yang, Wei He, T. Schwenzer et al.
Geburtshilfe und Frauenheilkunde
Neurofibromatosis and Schwannoma Cases
article

Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix – A Systematic Literature Review and New Case Report with Possible New Therapeutic Approaches

Zihao Hu, Zhi Yang, Wei He, T. Schwenzer, Qin Wang
article en

Abstract

Malignant schwannomas of the visceral organs are extremely rare. To date, 19 cases of cervical schwannoma have been reported in the literature worldwide. A single case prompted a review of the literature. The differential diagnosis between melanoma and schwannoma is made using the marker HMB-45, which is positive for melanoma and negative for schwannoma. This differentiation allowed us to identify two of the 20 cases that were probably not schwannomas. The prognosis of malignant cervical schwannoma is poor. Approximately half of the cases develop local recurrence or distant metastases within a short time, despite resection in healthy tissue. In one case, gene sequencing revealed a potential treatment approach with the mTOR inhibitor everolimus and trastuzumab. Unfortunately, the potential efficacy of these treatment options could not be tested because the patient was being treated at another hospital at the time of relapse, and they did not use a drug that matched the NGS profile.

Geburtshilfe und FrauenheilkundeVol. 85(04)
Southwest Medical University (CN)
Good health and well-being
Openalex Percentile: Top 64%
Neurofibromatosis and Schwannoma Cases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.